TELA Bio (TELA) Deferred Taxes (2025)

TELA Bio (TELA) posted quarterly Deferred Taxes of $7.2 million for Q4 2025, up 21809.09% quarter-over-quarter from $33000.0 in Q2 2025.

TELA Bio (TELA) Deferred Taxes (2025) Analysis & Trends

TELA Bio's Deferred Taxes history runs 1 years deep, the most recent figure standing at $7.2 million for Q4 2025.

In Q4 2025, Deferred Taxes changed N/A year-over-year to $7.2 million; the TTM figure through Dec 2025 stood at $7.3 million (changed N/A YoY), while the FY2025 annual figure was $7.3 million, up 5179.86% from the prior year.
Deferred Taxes for Q4 2025 stood at $7.2 million, up from $33000.0 in the prior quarter.
The five-year high for Deferred Taxes was $7.2 million in Q4 2025, with the low at $33000.0 in Q2 2025.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Deferred Taxes (Qtr)
1	Abbott Laboratories	198.70 Bn	193.10 Bn	7.27 Bn	-
2	Stryker	125.85 Bn	122.37 Bn	4.50 Bn	107.00 Mn
3	Medtronic	118.44 Bn	109.22 Bn	6.41 Bn	-8.00 Mn
4	Boston Scientific	72.64 Bn	72.10 Bn	3.85 Bn	17.00 Mn
5	Edwards Lifesciences	51.94 Bn	47.69 Bn	1.35 Bn	-181.30 Mn
6	Dexcom	34.48 Bn	32.53 Bn	830.00 Mn	-300,000.00
7	GE HealthCare Technologies	33.60 Bn	31.49 Bn	2.18 Bn	-
8	Koninklijke Philips	26.30 Bn	22.98 Bn	4.55 Bn	235.96 Mn
9	Steris	23.00 Bn	22.52 Bn	684.20 Mn	600,000.00
10	TELA Bio	36.34 Mn	5.92 Mn	13.94 Mn	-

Download Data